ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, vol.144, no.6, pp.735-741, 2020 (SCI-Expanded)
Article / Article
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Public Affairs Index
Istanbul University Affiliated:
Context.-The ability to determine ROS1 status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with ROS1-positive lung adenocarcinoma.